Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results

Autor:	J.M. Piulats, E. Yu, G. Gravis, B. Laguerre, J. Arranz, S. Oudard, P. Fong, M. Kolinsky, M. Augustin, S. Feyerabend, A.. Kam, H. Gurney, A. Tafreshi, M. Retz, W. Berry, N. Mar, H. Wu, C. Schloss, C. Poehlein, J. De Bono
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Diseases of the genitourinary system. Urology RC870-923 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	European Urology Open Science, Vol 19, Iss , Pp e873-e874 (2020)
Druh dokumentu:	article
ISSN:	2666-1683
DOI:	10.1016/S2666-1683(20)33164-5
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/08f97e7f76174b1e9aeba4c51c46fe8e Zobrazit plný text záznamu View record in DOAJ